Alan D Snow

This inventor holds 61 USPTO granted patents and 16 published patent applications, plus 5 CIPO patents and 8 EPO patents, primarily in Neurodegenerative Diseases (CPC class C07D). Top assignees: Proteotech Inc., University of Washington, Cognitive Clarity Inc.. Active years: 1999-2022.

USPTO Granted Patents = 61 (Patent Applications = 16)

% Patents Active = 34.4

CIPO Patents = 5

EPO Patents = 8 (Patent Applications = 5)

Average Co-Inventor Count = 2.8

ph-index = 10

Forward Citations = 361(Granted Patents)

Forward Citations (Not Self Cited) = 286(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Seattle, WA (US) (1999 - 2002)
Lynnwood, CA (US) (2009)
Lynwood, WA (US) (2010)
Lynnwood, WA (US) (2000 - 2022)
Edmonds, WA (US) (2022)

Company Filing History:

University of Washington

patents

4 out of 4

Cognitive Clarity Inc.

5. 8 out of 834,411

Other

patents

Years Active: 1999-2022

Loading Chart...

Areas of Expertise:

Alzheimer's Disease

Tauopathies

Amyloid Diseases

Neurodegenerative Diseases

Synucleinopathies

Beta-Amyloid

Procyanidin B2

Sirtuin 1

Small Peptides

Inflammatory Diseases

IAPP Accumulation

Perlecan

61 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11491201 - Compositions and methods for the treatment of 'plaques and tangles' in humans and animals (2022-11-08),

2. 11376300 - Compositions and methods for the treatment of plaques and tangles in humans and animals (2022-07-05),

3. 10350258 - Compositions and methods for the treatment of plaques and tangles in humans and animals (2019-07-16),

4. 10307454 - Compositions and methods for the treatment of 'plaques and tangles' in humans and animals (2019-06-04),

5. 9469605 - Compounds and compositions for use a modulators of tau aggregation and alleviation of tauopathies (2016-10-18),

6. 9334251 - Compounds for the treatment of neurodegenerative diseases (2016-05-10),

7. 9169255 - Caffeinated compounds and compositions for treatment of amyloid diseases and synucleinopathies (2015-10-27),

8. 9133176 - Isolation, purification and synthesis of procyanidin B2 and uses thereof (2015-09-15),

9. 9085549 - Compounds for the treatment of neurodegenerative diseases (2015-07-21),

10. 9051253 - Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's (2015-06-09),

11. 8956818 - Proteoglycan splice variants as therapeutics and diagnostics for amyloid diseases (2015-02-17),

12. 8916598 - Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies (2014-12-23),

13. 8895554 - Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease (2014-11-25),

14. 8865754 - Compounds for the treatment of neurodegenerative diseases (2014-10-21),

15. 8829198 - Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies (2014-09-09),

Title: Alan D. Snow: Innovator in Neuroscience and Therapeutics

Introduction:

Alan D. Snow, based in Lynnwood, WA, is a prominent inventor known for his significant contributions to neuroscience and therapeutic interventions. With an impressive portfolio of 61 patents, Snow's work focuses on innovative solutions for treating complex neurological conditions.

Latest Patents:

Among his latest groundbreaking patents are compositions and methods for the treatment of 'plaques and tangles' in humans and animals. One notable invention involves a method that comprises the administration of a therapeutically effective amount of a composition containing black currant extract and oolong tea extract. Another patent highlights a similar approach, utilizing Uncaria extract in combination with oolong tea extract, to effectively treat brain plaques and tangles, aiming to improve the health outcomes of subjects suffering from neurological disorders.

Career Highlights:

Throughout his career, Alan D. Snow has made significant strides in the field of neuroscience. He has worked with notable organizations, including Proteotech Inc. and the University of Washington, where his research and innovations have garnered attention within the scientific community.

Collaborations:

Snow's journey as an inventor has seen him collaborate with esteemed colleagues such as Gerardo M. Castillo and Thomas P. Lake. Their collective expertise has contributed to advancements in therapeutic methods, particularly in addressing neurological conditions.

Conclusion:

Alan D. Snow’s innovative spirit and dedication to scientific research continue to impact the field of neuroscience. His patents reflect a commitment to advancing therapeutic methods, underscoring the importance of collaboration and innovation in creating solutions for complex health issues.